Unlock instant, AI-driven research and patent intelligence for your innovation.

Omega-3 fatty acid ester compositions

A technology of fatty acid ester and composition, applied in the field of omega-3 fatty acid ester composition, can solve the problems of uncertainty of final success and high cost of new drugs

Inactive Publication Date: 2019-07-05
微团生物制药有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, discovery of new drugs is costly and eventual success is uncertain

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Omega-3 fatty acid ester compositions
  • Omega-3 fatty acid ester compositions
  • Omega-3 fatty acid ester compositions

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0187] The amounts and percentages of these ingredients making up the composition are shown in Table 1:

[0188] Table 1

[0189]

[0190]

[0191] The manufacturing process of a dosage form comprising the composition of an embodiment can be divided into three stages: a) the process of manufacturing the composition (fill mass), b) the process of manufacturing the gel mass used to encapsulate the fill mass, and c) Encapsulation process. Stages (a) and (b) can be carried out in either order.

[0192] The process of making the composition was started by weighing the appropriate amount of Polysorbate 80 and Pluronic F87 according to the desired batch size and mixing them well in a stainless steel tank at 60°C. The substantially pure omega-3 fatty acid ethyl ester mixture was allowed to cool to room temperature before quantitative vacuum transfer to the same stainless steel tank containing polysorbate 80 and Pluronic F87. This mixture was again mixed well at room temperatu...

example 2

[0196]Experiments were carried out to determine the micellar information in the two compositions A and B, as shown in Table 2. Two compositions comprising omega-3 fatty acid ethyl esters were prepared as described in Example 1, wherein the omega-3 fatty acid ethyl esters had increased absorption and the food effect was substantially eliminated.

[0197] Table 2

[0198]

[0199]

[0200] These compositions which form well dispersed micelles generally have a combined surfactant HLB value of from about 15 to about 17.

[0201] Other compositions having polysorbate 80 levels between 27% and 29% combined with Pluronic F87 between about 7% and about 22% generally formed large oil globules. These compositions have combined surfactant HLB values ​​from about 17 to about 19. Based on these experiments, the complete product has an HLB of from about 13 to about 14.4, and the combined surfactant HLB is between 12 and about 17.

example 3

[0203] Compositions A and B (1,000 mg) as shown in Table 2 were added to Separate container containing 500-900 mL of water in 0.1 N HCl and observe. Neither composition was subjected to any agitation or shearing. When viewed under a microscope, very small, well-dispersed micelles are visible. The micelles were stable over twelve months at room temperature, and the omega-3 fatty acid esters did not visibly separate from the other ingredients of the composition. Thus, compositions comprising polysorbate 80 levels between 20% and 31% in combination with 0.7% to 5% Pluronic F87 formed stable micelles.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The application discloses OMEGA-3 fatty acid ester compositions. Described specially herein is a medical composition comprising at least one Omega-3 fatty acid ester and at least one surface active agent, wherein the at least one omega-3 fatty acid ester constitutes at least about 40% (wt / wt) of the composition, and wherein the composition is free of omega-3 free fatty acids, wherein the at leastone omega-3 fatty acid ester forms a micelle upon contact with an aqueous medium, and the bioavailability of the at least one omega-3 fatty acid ester is substantially unaffected by food effects. Thecomposition is useful for the treatment of cardiovascular disorders or disorders in a subject and for the reduction of side effects associated with ingestion of the omega-3 fatty acid ester.

Description

[0001] This application is a divisional application with an application date of March 11, 2013, an application number of 201380027275.8, and an invention title of "ω-3 fatty acid ester composition". Background technique [0002] According to the World Health Organization (WHO) Briefing Note on Cardiovascular Disease (CVD), CVD is the number one cause of death worldwide. (Brief No. 317, accessed September 2012 (http: / / www.who.int / mediacentre / factsheets / fs317 / en / index.html, accessed January 31, 2013). According to WHO estimates, in 2008 an estimated 17.3 million people died from CVD, accounting for 30% of all deaths worldwide. Of these deaths, an estimated 7.3 million were due to coronary heart disease (CHD) and 6.2 million were due to stroke. WHO also estimates that by 2030 , almost 25 million people will die from CVD, mainly from heart disease and stroke. According to The Global Burden of Disease Study (The Global Burden of Disease Study) estimates that in 1990, of the 6.2 mil...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/202A61K31/232A61P3/00A61P25/24A61P29/00A61P1/16A61P35/00A61P9/12A61P3/06A61P9/10A61P9/04A61P9/06A61P7/02
CPCA61K9/1075A61K9/4858A61K31/05A61K31/232A61K31/7024A61K47/10A61K47/26A61K2300/00A61K31/355A61P1/16A61P11/00A61P25/24A61P29/00A61P3/00A61P35/00A61P3/06A61P7/02A61P9/00A61P9/04A61P9/06A61P9/10A61P9/12A61P9/14A61K45/06A61K47/06A61K47/22A61K47/34A61K47/44
Inventor 弗雷德里克·桑茨利奥彼得·珀西卡纳贾尼丝·卡卡切穆罕德·达黑姆
Owner 微团生物制药有限公司